Navigation Links
DrugRisk News: Court Consolidates Januvia Lawsuits Alleging Cancer
Date:9/4/2013

New York, NY (PRWEB) September 04, 2013

The diabetes drug safety center at DrugRisk.com is announcing new information on the site for patients taking the medications Januvia or Janumet. A federal panel recently ordered the consolidation of a growing number of lawsuits alleging the drugs caused pancreatic cancer*.

DrugRisk is a resource center designed to give patients taking popular prescription drugs like Januvia the latest warnings, recalls, studies and legal news. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Januvia and Janumet are diabetes medications prescribed to those with type-2 diabetes, taken twice a day to lower blood sugar levels. In recent years, they have been the best-selling drugs for Merck, bringing in over $4 billion last year**.

However, DrugRisk has added studies that link Januvia and Janumet to cancer. A 2011 study from UCLA linked Januvia with increased rates of pancreatic cancer and thyroid cancer***. The American Medical Association recently advised diabetes drugs like these can double the risk of pancreatitis, a major risk factor for pancreatic cancer****.

Now, with a growing number of patients filing a Januvia lawsuit alleging cancer, the Judicial Panel on Multidistrict Litigation ordered last week that cases will be consolidated to a special multidistrict litigation federal court. (In Re: Incretin-Based Therapies Products Liability Litigation, MDL 2452, Southern District of California)*.

Anyone affected by cancer after taking Januvia or Janumet is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Januvia lawsuits.

For more information on the research, side effects and litigation news related to Januvia and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*JPML 8/26/13; jpml.uscourts.gov/sites/jpml/files/MDL-2452-Initial_Transfer-07-13.pdf
**Bloomberg, 2/25/13; bloomberg.com/news/2013-02-25/merck-bristol-diabetes-drugs-linked-to-pancreatitis-risk.html
***Gastroenterology, July 2011; ctsi.ucla.edu/education/files/publicview/training/docs/FDA-analysis.pdf
****JAMA Internal Medicine, 2/25/13; archinte.jamanetwork.com/article.aspx?articleid=1656537

Read the full story at http://www.prweb.com/releases/2013-januvia-side-effects/lawsuit-litigation/prweb11085046.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Update: Court Issues Latest Decision in Pradaxa Bleeding Litigation
2. DrugRisk Update: New Study Warns of Pradaxa Dangers as Lawsuits Increase
3. DrugRisk Update: Panel To Decide Fate of Januvia Lawsuits Next Week
4. DrugRisk Announces Latest Ruling By Judicial Panel on NuvaRing Lawsuits
5. DrugRisk Announces Drop in Yaz Lawsuits As Bayer Commits $1.5 Billion to Settlements
6. DrugRisks Announces Yaz Center With Latest Updates on Blood Clot Warnings and Settlements
7. DrugRisks Update: New Study Warns of Pradaxa Brain Bleeding
8. DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits
9. Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes
10. DrugRisk News: Federal Panel Issues Latest Mirena Lawsuit Updates
11. DrugRisks Update: Latest Court Figures Show Rise In Pradaxa Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... In the United States alone, up to 36% ... other types of metastatic brain tumors(3). Though most meningiomas are benign, metastatic brain tumors ... finding more effective treatment options, the San Diego Gamma Knife Center offers ...
(Date:3/29/2017)... ... 30, 2017 , ... Youth Futures International (YFI) premiered its Serve, Learn, & ... and college students who have participated in the program every summer. The 2017 ... accepting applications for enrollment. Visit http://www.ghana.yfiexperience.org to learn more. , “I ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... without a referral to new patients from Burnaby, BC. Patients in need of ... mouth reconstruction services, can see the esteemed team at Wall Centre Dental. Drs. ...
(Date:3/29/2017)... ... March 29, 2017 , ... How big is the ... and who are the most active developers? , In the first independently ... Estate Insights (HREI) found that outpatient medical real estate development projects totaling nearly ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... in many scientific laboratories. The assembly protocols involve many repetitive steps and often ... for automation, which enables the high-throughput needed, and results in a lower error ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017 Research and Markets has announced the ... Therapy Centers & Forecast" report to their offering. ... Proton Therapy Market in Italy ... value in 2016. There are currently three proton therapy centers in ... more patients. In Italy , the first patients were ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "South Korean ... Forecast" report to their offering. ... The South Korean Proton Therapy Market is expected to almost ... Proton Therapy Market for South Korea was valued ... Therapy plays an important role in delivering comprehensive cancer care to children ...
(Date:3/29/2017)... BEACH, Calif. , March 29, 2017 /PRNewswire/ ... have recognized remote monitoring devices like  Soberlink Systems ...   The consensus paper, published in early 2017, ... practical and valuable in managing patient recovery." ... in the Journal of Addiction Medicine, detail a ...
Breaking Medicine Technology: